CEACAM5 and cholangiocarcinoma: The circulating levels of glycol phosphoprotein osteopontin were found markedly increased in patients with CCA, compared with either healthy controls (AUC of 0.964) and patients with PSC, providing a higher diagnostic accuracy than CA19-9 or CEA.